Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vincent Medical Holdings's cash flow for dividends for the
six
months ended in Dec. 2025 was HK$-15.5 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-26.4 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Vincent Medical Holdings's quarterly payment of dividends
increased
from Dec. 2024 (HK$-10.3 Mil) to Jun. 2025 (HK$-10.9 Mil) and
increased
from Jun. 2025 (HK$-10.9 Mil) to Dec. 2025 (HK$-15.5 Mil).
Vincent Medical Holdings's annual payment of dividends
increased
from Dec. 2023 (HK$-8.0 Mil) to Dec. 2024 (HK$-19.9 Mil) and
increased
from Dec. 2024 (HK$-19.9 Mil) to Dec. 2025 (HK$-26.4 Mil).
Vincent Medical Holdings Cash Flow for Dividends Related Terms
Vincent Medical Holdings Cash Flow for Dividends Historical Data
* Premium members only.
The historical data trend for Vincent Medical Holdings's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vincent Medical Holdings Cash Flow for Dividends Chart
Vincent Medical Holdings Cash Flow for Dividends Calculation
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-26.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of HK$-26.4 Mil mean?
Vincent Medical Holdings (HKSE:01612) has a Cash Flow for Dividends of HK$-26.4 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Vincent Medical Holdings and its competitors.
Is Vincent Medical Holdings' Cash Flow for Dividends too high?
Vincent Medical Holdings' current Cash Flow for Dividends is HK$-26.4 Mil. Overall, Vincent Medical Holdings has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vincent Medical Holdings' Cash Flow for Dividends compare to ABT and SYK?
Vincent Medical Holdings' Cash Flow for Dividends of HK$-26.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Vincent Medical Holdings and its competitors. Vincent Medical Holdings's current Cash Flow for Dividends is HK$-26.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincent Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vincent Medical Holdings (HKSE:01612) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.58, compared to a current price of HK$0.71 — trading 22.4% above its estimated fair value. The current Cash Flow for Dividends is HK$-26.4 Mil. Vincent Medical Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Vincent Medical Holdings (HKSE:01612), the current Cash Flow for Dividends is HK$-26.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vincent Medical Holdings (HKSE:01612) Overvalued in 2026?
Based on GuruFocus' analysis, Vincent Medical Holdings stock appears to be overvalued.
The current stock price of HK$0.71 is trading 22.4% above its estimated GF Value™ of HK$0.58.
GuruFocus considers Vincent Medical Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:01612:
Cash Flow for Dividends: HK$-26.4 Mil
GF Value™: HK$0.58 vs. price of HK$0.71 (22.4% above fair value)
No single metric tells the full story. See the HKSE:01612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices focusing on imaging disposable products on an OEM basis to one of the world's diagnostic imaging solutions providers. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer's requirements. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under the Inspired Medical, and Hand of Hope brands. The geographical segments of the company includes the United States, Spain, the PRC, Japan, Costa Rica, the Netherlands, Germany, and Others. It derives its maximum revenue from Spain.
49GF Score
Get the complete analysis for HKSE:01612
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01612 has been successfully added to your 
